Corcept Therapeutics | CORT - Trade Debtors



Corcept Therapeutics reported $64.57M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
Alaunos Therapeutics USD 5K 5K Dec/2024
ANI Pharmaceuticals USD 225.65M 5.32M Jun/2025
Ardelyx USD 62.55M 4.84M Jun/2025
Aurora Cannabis CAD 39.14M 10.38M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Canopy Growth CAD 50.03M 972K Jun/2025
Corcept Therapeutics USD 64.57M 2.75M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
J&J USD 16.02B 1.18B Mar/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Merck USD 12.72B 1.14B Jun/2025
Novartis USD 9.18B 451M Jun/2025
Novartis USD 9.18B 1.62B Jun/2025
Pacira USD 114.37M 9.62M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Supernus Pharmaceuticals USD 140.83M 4.81M Jun/2025
TG Therapeutics USD 231.52M 102.33M Jun/2025